癌症中的增强RNA:识别,表达,资源,与免疫的关系,药物和预后
Ruijie Zhang1, Zhengxin Chen1, Tianyi Li1
1College of Biomedical Informatics and Engineering, Kidney Disease Research Institute at the second affiliated hospital, Hainan Engineering Research Center for Health Big Data, Hainan Medical University, 3 Xueyuan Rd, Longhua District, Haikou, Hainan 571199, China.
增强型RNAs (eRNAs) 是基因表达和癌症的关键调节者. 本综述强调了 eRNA 在癌症,免疫治疗中的作用,以及它们作为精密瘤学的生物标志物的潜力.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 增强子RNA (eRNA) 是从增强子转录的非编码RNA,在基因调节中发挥关键作用.
- eRNA与瘤发生,转移和调节癌症治疗反应有关.
研究的目的:
- 审查 eRNA 识别和量化方法.
- 探索eRNAs在基因表达,蛋白质功能和染色质修饰中的功能性作用.
- 讨论eRNAs在癌症免疫学中的参与及其作为生物标志物的潜力.
主要方法:
- 通过增强剂预测,基因素修饰 (H3K4me1) 和核细胞定位来识别eRNA.
- 使用RNA-seq,单细胞转录组学和表观基因组数据集成的eRNA表达量化.
- 分析eRNA数据库及其相互作用.
主要成果:
- eRNAs调节基因表达,蛋白质功能和染色质结构.
- eRNAs参与免疫细胞交叉和瘤微环境重编程.
- eRNA签名显示出作为免疫疗法反应和化疗抵抗的预测生物标志物的潜力.
结论:
- 在癌症生物学中,eRNA是关键的调节元件,在精密瘤学中具有显著的潜力.
- 综合的多组学方法对于充分利用eRNA的临床适用性至关重要.
- eRNA为开发新型癌症诊断和治疗提供了有前途的途径.
更多相关视频
10:57Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
相关概念视频
Cancer
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
